Navigation Links
Medical Marijuana Inc. to Acquire Biotechnology Company PharmaSphere, LLC from Converted Organics
Date:11/18/2011

SAN DIEGO, Nov. 18, 2011 /PRNewswire/ -- Medical Marijuana Inc. (OTC: MJNA) is proud to announce the execution of an option to acquire 100% of PharmaSphere, LLC. PharmaSphere, a cutting edge biotechnology company which has a solution for the production of high value bio-compounds sourced from plants that can be used as active pharmaceutical ingredients. The production of transgenic plants (genetically engineered plants) for the biotechnology revolution is the cornerstone of PharmaSphere's focus and overall development for the plant based medical industry. PharmaSphere holds the exclusive worldwide license for medical herbs from TerraSphere systems.

TerraSphere Systems' (www.terraspheresystems.com) uniqueness for growing plants in environmentally contained and controlled growth environments created the first pharmaceutical grade environment for plant based compounds. These compounds will be used as ingredients for drugs, vaccines, diagnostics, nutraceuticals, cosmeceuticals, and industrial enzymes and materials.

PharmaSphere will install TerraSphere Systems inside retrofitted facilities in order to grow, extract and purify the compounds using environmental friendly technologies. Additional environmental benefits include substantially less water & fertilizer use due to metered dispensing, less waste water or fertilizer discharge due to plant uptake, no chemical pesticides or herbicides, no fuel and oil use by agricultural machinery, along with no transportation of bulk plant materials to distant processing facilities.

A major concern for sellers of natural product drugs, medical herbs, nutraceuticals, and cosmeceuticals is the unreliable supply of top quality active ingredients as the cultivation of source plants in the field and outdoors is erratic and the quality of extracts is uneven. With the TerraSphere System and state-of-the art extraction, purification and quality control technologies, the company can assure its customers a reliable consistent supply of high quality plant based compounds such as Cannabidiol, Vincristine and Vanblastine.

Medical Marijuana Inc. at the moment will be focusing on building PharmaSphere facilities that will cultivate medical herbs such as Madagascar Rosy Periwinkle, which is the source of the generic cancer chemotherapy compounds vincristine and vinblastine. These compounds have worldwide markets for the finished drugs in excess of $4.5 billion. Once facilities are built and the medical marijuana market is legally accepting of large scale commercialization, the facilities can be transitioned to grow any medicinal herb by simply changing seeds. However, the company does plan on building facilities in countries that legally allow the cultivation of medicinal marijuana and hemp for medical benefits.  A few examples of these countries are Israel, China, and France. Medical Marijuana Inc. anticipates closing the purchase prior to the end of the fiscal year.

About Medical Marijuana Inc. (OTC: MJNA)

The world's first publically traded Medical Marijuana company.  Our mission is to be the world's premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate, invest in and purchase value-added sustainable companies, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, pay homage to the visionaries and activists of the past and present, and provide the platform from which the industry can emerge into a global sustainable economy for all. Medical Marijuana Inc. recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.

www.medicalmarijuanainc.com
http://www.facebook.com/mjnainc

About PharmaSphere Systems, LLC:

PharmaSphere Systems, LLC is a biotechnology company that owns a perpetual worldwide license to utilize TerraSphere Systems technology to produce high-value, plant-based biocompounds for pharmaceutical, cosmeceutical and nutraceutical markets. Using the TerraSphere System allows PharmaSphere to achieve full environmental containment and controlled growth conditions, which result in increased production and reduced per-unit costs compared to traditional production methods. The use of the TerraSphere growth system also gives PharmaSphere Systems, LLC a market advantage through the unprecedented level of control and trace capabilities.

About TerraSphere Systems, LLC:

TerraSphere Systems (www.terraspheresystems.com) is dedicated to building highly efficient systems for growing pesticide-free fruits and vegetables in a controlled indoor environment. TerraSphere's clean technology helps to promote the sustainable consumption of natural resources by accelerating plant production and maximizing crop yields, while improving environmental footprints through the reduction of carbon emissions and fuel use associated with traditional crop production and distribution. TerraSphere's unique, environmentally and socially-responsible business model help to facilitate job creation and diverse, community-based workforces. TerraSphere believes its technology can potentially revolutionize access to organic produce for both remote and urban communities, alleviate land management issues for agricultural producers, and ease hunger crises for the world's growing population.

About Converted Organics Inc.:

Converted Organics (www.convertedorganics.com), based in Boston, MA, is dedicated to producing high-quality, all-natural, organic soil amendment and fertilizer products through food waste recycling. The Company uses its proprietary High Temperature Liquid Composting (HTLC) system, a proven, state-of-the-art microbial digestion technology, to process various biodegradable food wastes into dry pellet and liquid concentrate organic fertilizers that help grow healthier food and improve environmental quality. Converted Organics sells and distributes its environmentally-friendly fertilizer products in the retail, professional turf management, and agribusiness markets.

Investor Relations Contact:

Equiti-Trend Advisors, LLC
Carmel Valley Center II
11995 El Camino Real, Suite 301
San Diego, CA 92130
(800) 953-3350
www.equititrend.com


'/>"/>
SOURCE Medical Marijuana Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Medical Technologies Reports Second Fiscal Quarter Financial Results
2. United Spinal Secures Leading Public Policy and Durable Medical Equipment Specialist: Alex Bennewith is New Director of Government Relations
3. Restrictions on use of Hazardous Substances in Electronic and Electric Devices Spur Medical Device OEMs to Find Alternatives
4. Cohera Medical Commercializes TissuGlu® Surgical Adhesive in Germany
5. Nonin Medical Announces Launch of Worlds First and Only OEM Solution for Regional Oximetry at Medica Congress
6. Genesis Biopharmas Scientific and Medical Advisory Board Welcomes Dr. Steven A. Rosenberg, Chief of the Surgery Branch at the NCI
7. SurgiCount Medical Announces Agreement with Premier Healthcare Alliance
8. U.S. Biomedical Leaders Present Leaders on Capitol Hill with New National Strategy for Innovation
9. Aethlon Medical Releases Shareholder Letter
10. HASCO Medical Announces Third Quarter 2011 Financial Results
11. Boston Scientific Applauds Introduction of Patient Access to Medical Innovation Act
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at www.diabetesscholars.org by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® ... Group (TGIG), has initiated cultivation and processing operations at its production facility, and ... Nevada. , Puradigm is the manufacturer of a complete system of proactive air ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Venture Construction ... Classic Tournament held on June 20th at the Woodmont Country Club at 1201 ... Wings, an organization dedicated to helping service members that have been wounded in battle ...
Breaking Medicine News(10 mins):